Iconovo develops new inhaled medicinal products in collaboration with international pharmaceutical companies. We have several types of patented dry powder inhalers that can create significant commercial opportunities for the development of both new pharmaceuticals and generic medicine. Our strength is our inhouse capabilities with full control over both device development and formulation, meaning less risk and faster time to market.
Looking for a particular Iconovo AB employee's phone or email?
The Iconovo AB annual revenue was $6.1 million in 2026.
Henrik Simonsen is the CFO of Iconovo AB.
27 people are employed at Iconovo AB.
Iconovo AB is based in Lund, Skåne County.
The NAICS codes for Iconovo AB are [3254, 32, 32541, 325].
The SIC codes for Iconovo AB are [283, 28].